- Home
- MIRM vs ACT Comparison
MIRM vs ACT Comparison
Compare MIRM & ACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIRM | ACT |
|---|---|---|
| Founded | 2018 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.8B |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MIRM | ACT |
|---|---|---|
| Price | $106.24 | $42.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 4 |
| Target Price | ★ $119.85 | $44.25 |
| AVG Volume (30 Days) | ★ 667.9K | 233.2K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.90% |
| EPS Growth | ★ 74.59 | 3.43 |
| EPS | N/A | ★ 1.18 |
| Revenue | $19,138,000.00 | ★ $1,235,827,000.00 |
| Revenue This Year | $26.22 | $4.06 |
| Revenue Next Year | $22.04 | $2.33 |
| P/E Ratio | ★ N/A | $36.34 |
| Revenue Growth | N/A | ★ 2.83 |
| 52 Week Low | $42.89 | $33.94 |
| 52 Week High | $112.00 | $44.80 |
Technical Indicators
Market Signals| Indicator | MIRM | ACT |
|---|---|---|
| Relative Strength Index (RSI) | 62.25 | 50.74 |
| Support Level | $87.26 | $39.43 |
| Resistance Level | $107.51 | $44.66 |
| Average True Range (ATR) | 5.87 | 1.11 |
| MACD | 0.98 | -0.10 |
| Stochastic Oscillator | 75.13 | 35.48 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About ACT Enact Holdings Inc.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The company operates in a single reportable segment namely Mortgage Insurance The principal mortgage insurance customers are originators of residential mortgage loans that determines the mortgage insurer or insurers to be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.